ALHC Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

25.120

Open

24.748

VWAP

24.35

Vol

4.21M

Mkt Cap

4.97B

Low

23.870

Amount

102.37M

EV/EBITDA(TTM)

68.13

Total Shares

206.73M

4.67B

EV/OCF(TTM)

18.55

P/S(TTM)

1.20

Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.

Events Timeline

(ET)

2026-05-12

16:40:00

Alignment Healthcare Announces Leadership Updates, Kao as Chairman

2026-05-01 (ET)

2026-05-01

16:10:00

Apple Raises Quarterly Dividend and Announces $100B Stock Buyback

2026-05-01

12:00:00

Apple Reports Strong Earnings, Raises Dividend and Announces $100B Buyback

News

8.5

07-03NASDAQ.COM

Ensign Group Acquires Texas Nursing Facilities to Expand Operations

6.5

07-03Yahoo Finance

Analysis of Market Performance of Three Stocks

5.0

06-30Fool

Alignment Healthcare Executive Sells Shares

5.0

06-30NASDAQ.COM

Executive Stock Sale Raises Market Concerns

5.0

06-24Fool

Alignment Healthcare Executive Sells Shares

5.0

06-24NASDAQ.COM

Konowiecki Sells 25,000 Shares of Alignment Healthcare

9 Analyst Rating

Wall Street analysts forecast ALHC stock price to rise

7 Buy

2 Hold

0 Sell

Strong Buy

Current: 0.000

Low

18.00

Averages

21.81

High

30.00

Current: 0.000

Low

18.00

Averages

21.81

High

30.00

Barclays

Equal Weight

downgrade

$19 -> $16

AI Analysis

2026-05-26

Reason

Barclays

Price Target

$19 -> $16

AI Analysis

2026-05-26

downgrade

Equal Weight

Reason

Barclays lowered the firm's price target on Alignment Healthcare to $16 from $19 and keeps an Equal Weight rating on the shares. The firm believes the managed care stock moves post the Q1 reports are "durable." It continues to prefer managed care over facilities, saying inflation and commercial mix represent increasing drivers of provider earnings risk. Barclays adjusted ratings and targets in the group.

Raymond James

Strong Buy

downgrade

$27 -> $22

2026-05-07

Reason

Raymond James

Price Target

$27 -> $22

2026-05-07

downgrade

Strong Buy

Reason

Raymond James lowered the firm's price target on Alignment Healthcare to $22 from $27 and keeps a Strong Buy rating on the shares. The stock has been under pressure since "a solid quarter" with "some minor hiccups around the hospital payments issue that appear to be contained," says the analyst, who attributes the post-earnings weakness to a "relatively expensive valuation," the fact that Q1 had "some small hiccups," and potentially some rotation into other large cap managed care organizations.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ALHC

Unlock Now

Valuation Metrics

The current forward P/E ratio for Alignment Healthcare Inc (ALHC.O) is 204.08, compared to its 5-year average forward P/E of -44.87. For a more detailed relative valuation and DCF analysis to assess Alignment Healthcare Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-44.87

Current PE

204.08

Overvalued PE

378.13

Undervalued PE

-467.87

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-69.07

Current EV/EBITDA

33.47

Overvalued EV/EBITDA

240.06

Undervalued EV/EBITDA

-378.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.03

Current PS

0.76

Overvalued PS

1.72

Undervalued PS

0.34

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

most profit stock on Wednesday

Intellectia · 2823 candidates

Market Cap: >= 300.00MRegion: USPrice: >= $1.00List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000

Ticker

Name

Market Cap$

MOVE

Corvex, Inc

809.51M

CAR

Avis Budget Group Inc

9.01B

ALHC

Alignment Healthcare Inc

4.43B

ACIU

AC Immune SA

316.52M

ARMP

Armata Pharmaceuticals Inc

437.76M

OVID

Ovid Therapeutics Inc

386.63M

swing trade mejores posiciones hoy

Intellectia · 104 candidates

Market Cap: >= 2.00BPrice Change Pct: $2.00 - $8.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

PLUG

Plug Power Inc

3.25B

AT&T Inc

167.24B

IREN

IREN Ltd

18.49B

DNN

Denison Mines Corp

3.51B

Micron Technology Inc

439.39B

CLSK

CleanSpark Inc

3.23B

Whales Holding ALHC

Granahan Investment Management, LLC

Hood River Capital Management LLC

General Atlantic Service Company, L.P.

LGT Fund Management Company AG

Trading Trends

People Also Watch

Frequently Asked Questions

What is Alignment Healthcare Inc (ALHC) stock price today?

The current price of ALHC is 24.05 USD — it has decreased -2.08

What is Alignment Healthcare Inc (ALHC)'s business?

What is the price predicton of ALHC Stock?

Wall Street analysts forecast ALHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALHC is21.81 USD with a low forecast of 18.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.